Coronavirus vaccine compositions and methods
US12220455B2 · kind B2 · utility
0Cited by
15References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2023 |
| Grant date | Feb 11, 2025 |
| Priority date | — |
| Expiry date | Jun 30, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are nucleic acid molecules encoding viral replication proteins and antigenic coronavirus proteins or fragments thereof. Also provided herein are compositions that include nucleic acid molecules encoding viral replication and antigenic proteins, and lipids. Nucleic acid molecules provided herein are useful for inducing immune responses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.